Financials data is unavailable for this security.
View more
Year on year Mevis Medical Solutions AG 's revenues fell -7.57% from 18.76m to 17.34m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 7.79m to 4.92m, a -36.84% decrease.
| Gross margin | 97.24% |
|---|---|
| Net profit margin | 32.60% |
| Operating margin | 26.74% |
| Return on assets | 23.24% |
|---|---|
| Return on equity | 32.27% |
| Return on investment | 28.00% |
More ▼
Cash flow in EURView more
In 2023, cash reserves at Mevis Medical Solutions AG fell by 1.58m. However, the company earned 5.85m from its operations for a Cash Flow Margin of 33.76%. In addition the company generated 989.98k cash from investing, though they paid out 7.79m more in financing than they received.
| Cash flow per share | 3.22 |
|---|---|
| Price/Cash flow per share | 7.51 |
| Book value per share | 9.79 |
|---|---|
| Tangible book value per share | 9.79 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.80 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in EUR
SmartText is unavailable
| Div yield(5 year avg) | 3.03% |
|---|---|
| Div growth rate (5 year) | 0.00% |
| Payout ratio (TTM) | 30.06% |
| EPS growth(5 years) | -8.38 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -7.19 |
More ▼
